Research highlights AAV manufacturing optimization via Lexeo’s Sf9-baculovirus processNEW YORK, May 01, 2025 (GLOBE NEWSWIRE) ...

This week's Guest Voice is Richard Bayliss, who talks about three coping tools he's found useful in living with sickle cell ...

After months of tense negotiations, the US and Ukraine signed a deal that will give Washington access to the country’s ...

Fulcrum continues to advance its program for the potential treatment of inherited aplastic anemias, such as Diamond-Blackfan anemia (DBA), Shwachman-Diamond syndrome, and Fanconi anemia, and plans to ...

A federal judge last month dismissed an incarcerated man's claims against officials in Colorado's "supermax" prison alleging ...

A man who recorded with his cell phone the moment Grand Rapids police officer Christopher Schurr fatally shot Patrick Lyoya ...

All pregnant patients at M Health Fairview will be screened and tested for maternal and fetal conditions, with race removed ...

About Dr. Brandicourt Dr. Brandicourt is a distinguished executive in the biopharmaceutical industry. He is currently a Senior Advisor at Blackstone Life Sciences and serves on the boards of Alnylam ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune ...

TCE to demonstrate significant γδ T cell expansion and activation, potentially offering an alternative to conventional CD3-based approaches without significant adverse events such as cytokine release ...

How have the wild initial months of Donald Trump’s return to the White House landed on Washington? We asked the people who ...